Ultrasmall Nanoparticle Delivery of Doxorubicin Improves Therapeutic Index for High-Grade Glioma.
Virginia Aragon-SanabriaAnusha AdityaLi ZhangFeng ChenBarney YooTianye CaoBrian MadajewskiRachel LeeMelik Z TurkerKai MaSebastien MonettePeiming ChenJing WuShutian RuanMichael OverholtzerPat ZanzonicoCharles M RudinCameron BrennanUlrich WiesnerMichelle S BradburyPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Ultrasmall C' dot-drug conjugates showed great translational potential over DOX for improving the therapeutic outcome of patients with high-grade gliomas, even without a cancer-targeting moiety.